- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs will have significant change from previous year. By the most conservative estimates of global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1227.3 million in 2020. Over the next five years the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market will register a 11.1% CAGR in terms of revenue, the global market size will reach US$ 1869.9 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
XIFAXAN
Viberzi
Lotronex
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals Pharmacy
Retail Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption 2016-2026
2.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption CAGR by Region
2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
2.2.1 XIFAXAN
2.2.2 Viberzi
2.2.3 Lotronex
2.2.4 Other
2.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
2.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2016-2021)
2.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel
2.4.1 Hospitals Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
2.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Market Share by Sales Channel (2016-2021)
2.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Sales Channel (2016-2021)
2.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2016-2021)
3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company
3.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2019-2021)
3.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2019-2021)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company
3.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2019-2021)
3.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company
3.4 Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Location Distribution
3.4.2 Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region
4.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
4.5 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth
5 Americas
5.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
5.1.1 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2016-2021)
5.1.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2016-2021)
5.2 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
5.3 Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
6.1.1 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2016-2021)
6.1.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2016-2021)
6.2 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
6.3 APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2016-2021)
7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2016-2021)
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country
8.1.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type
8.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer
11 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast
11.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Region
11.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Regions (2021-2026)
11.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Type
11.7 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast by Sales Channel
12 Key Players Analysis
12.1 Bausch Health
12.1.1 Bausch Health Company Information
12.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
12.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bausch Health Main Business Overview
12.1.5 Bausch Health Latest Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
12.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Allergan Main Business Overview
12.2.5 Allergan Latest Developments
12.3 Sebela Pharmaceuticals
12.3.1 Sebela Pharmaceuticals Company Information
12.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
12.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sebela Pharmaceuticals Main Business Overview
12.3.5 Sebela Pharmaceuticals Latest Developments
12.4 Astellas Pharmaceuticals
12.4.1 Astellas Pharmaceuticals Company Information
12.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
12.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Astellas Pharmaceuticals Main Business Overview
12.4.5 Astellas Pharmaceuticals Latest Developments
12.5 Amneal Pharms
12.5.1 Amneal Pharms Company Information
12.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
12.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Amneal Pharms Main Business Overview
12.5.5 Amneal Pharms Latest Developments
12.6 Pharscin Pharma
12.6.1 Pharscin Pharma Company Information
12.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
12.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pharscin Pharma Main Business Overview
12.6.5 Pharscin Pharma Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of XIFAXAN
Table 3. Major Players of Viberzi
Table 4. Major Players of Lotronex
Table 5. Major Players of Other
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2016-2021) & ($ million)
Table 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2016-2021)
Table 10. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Type (2016-2021)
Table 11. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Value by Sales Channel (2016-2021)
Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2016-2021)
Table 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Sales Channel (2016-2021)
Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2019-2021) & (K Units)
Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2019-2021)
Table 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company (2019-2021)
Table 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Producing Area Distribution and Sales Area
Table 22. Players Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
Table 23. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2016-2021) (K Units)
Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2016-2021)
Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2016-2021)
Table 30. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2016-2021)
Table 32. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2016-2021)
Table 34. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 35. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 36. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 37. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 38. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2016-2021) & (K Units)
Table 39. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2016-2021)
Table 40. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2016-2021)
Table 42. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 43. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 44. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 45. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 46. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2016-2021) & (K Units)
Table 47. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2016-2021)
Table 48. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2016-2021)
Table 50. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 51. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 52. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 53. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 54. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Sales Channel (2016-2021) & (K Units)
Table 61. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Table 62. Key and Potential Regions of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 63. Key Application and Potential Industries of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 64. Key Challenges of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 65. Key Trends of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Table 66. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table 67. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customer List
Table 68. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Forecast by Region
Table 70. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Sales Channel (2021-2026) & (K Units)
Table 85. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Sales Channel (2021-2026)
Table 86. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Sales Channel (2021-2026) & ($ Millions)
Table 87. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Sales Channel (2021-2026)
Table 88. Bausch Health Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
Table 90. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Bausch Health Main Business
Table 92. Bausch Health Latest Developments
Table 93. Allergan Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
Table 95. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Allergan Main Business
Table 97. Allergan Latest Developments
Table 98. Sebela Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
Table 100. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Sebela Pharmaceuticals Main Business
Table 102. Sebela Pharmaceuticals Latest Developments
Table 103. Astellas Pharmaceuticals Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
Table 105. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Astellas Pharmaceuticals Main Business
Table 107. Astellas Pharmaceuticals Latest Developments
Table 108. Amneal Pharms Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
Table 110. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Amneal Pharms Main Business
Table 112. Amneal Pharms Latest Developments
Table 113. Pharscin Pharma Basic Information, Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offered
Table 115. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Pharscin Pharma Main Business
Table 117. Pharscin Pharma Latest Developments
List of Figures
Figure 1. Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of XIFAXAN
Figure 10. Product Picture of Viberzi
Figure 11. Product Picture of Lotronex
Figure 12. Product Picture of Other
Figure 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2016-2021)
Figure 15. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Hospitals Pharmacy
Figure 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Hospitals Pharmacy (2016-2021) & (K Units)
Figure 17. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Retail Pharmacy
Figure 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Retail Pharmacy (2016-2021) & (K Units)
Figure 19. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumed in Other
Figure 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Other (2016-2021) & (K Units)
Figure 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2016-2021)
Figure 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel in 2020
Figure 23. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Company in 2020
Figure 25. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions (2016-2021)
Figure 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region in 2020
Figure 27. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2021 (K Units)
Figure 28. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2016-2021 ($ Millions)
Figure 29. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2021 (K Units)
Figure 30. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2016-2021 ($ Millions)
Figure 31. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2021 (K Units)
Figure 32. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2020
Figure 36. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country in 2020
Figure 37. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 38. Americas Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 39. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region in 2020
Figure 44. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions in 2020
Figure 45. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 46. APAC Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 47. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2020
Figure 54. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country in 2020
Figure 55. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 56. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 57. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel in 2020
Figure 66. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
